285 related articles for article (PubMed ID: 24905725)
21. Carbohydrate metabolism during treatment of endometriosis with the progestin dienogest.
Nikschick S; Köhler G; Männchen E
Exp Clin Endocrinol; 1989 Sep; 94(1-2):211-4. PubMed ID: 2689190
[TBL] [Abstract][Full Text] [Related]
22. Norethindrone acetate or dienogest for the treatment of symptomatic endometriosis: a before and after study.
Vercellini P; Bracco B; Mosconi P; Roberto A; Alberico D; Dhouha D; Somigliana E
Fertil Steril; 2016 Mar; 105(3):734-743.e3. PubMed ID: 26677792
[TBL] [Abstract][Full Text] [Related]
23. Effective salvage of acute massive uterine bleeding using intrauterine balloon tamponade in a uterine adenomyosis patient on dienogest.
Nishino K; Hayashi K; Chaya J; Kato N; Yamamuro O
J Obstet Gynaecol Res; 2013 Mar; 39(3):738-41. PubMed ID: 23003209
[TBL] [Abstract][Full Text] [Related]
24. Current and Future Medical Therapies for Adenomyosis.
Cope AG; Ainsworth AJ; Stewart EA
Semin Reprod Med; 2020 May; 38(2-03):151-156. PubMed ID: 33124017
[TBL] [Abstract][Full Text] [Related]
25. The use of dienogest in treatment of symptomatic adenomyosis: A systematic review and meta-analysis.
Ali MK; Hussein RS; Abdallah KS; Mohamed AA
J Gynecol Obstet Hum Reprod; 2024 May; 53(7):102795. PubMed ID: 38729430
[TBL] [Abstract][Full Text] [Related]
26. Dienogest. A possible conservative approach in bladder endometriosis. Results of a pilot study.
Angioni S; Nappi L; Pontis A; Sedda F; Luisi S; Mais V; Melis GB
Gynecol Endocrinol; 2015 May; 31(5):406-8. PubMed ID: 25776993
[TBL] [Abstract][Full Text] [Related]
27. Dienogest is as effective as leuprolide acetate in treating the painful symptoms of endometriosis: a 24-week, randomized, multicentre, open-label trial.
Strowitzki T; Marr J; Gerlinger C; Faustmann T; Seitz C
Hum Reprod; 2010 Mar; 25(3):633-41. PubMed ID: 20089522
[TBL] [Abstract][Full Text] [Related]
28. Long-term use of dienogest for the treatment of endometriosis.
Momoeda M; Harada T; Terakawa N; Aso T; Fukunaga M; Hagino H; Taketani Y
J Obstet Gynaecol Res; 2009 Dec; 35(6):1069-76. PubMed ID: 20025633
[TBL] [Abstract][Full Text] [Related]
29. Effect and safety of high-dose dienogest (20 mg/day) in the treatment of women with endometriosis.
Schindler AE; Henkel A; Moore C; Oettel M
Arch Gynecol Obstet; 2010 Nov; 282(5):507-14. PubMed ID: 20012981
[TBL] [Abstract][Full Text] [Related]
30. Estradiol valerate/dienogest: a novel oral contraceptive.
Whalen KL; Rose R
Ann Pharmacother; 2011 Oct; 45(10):1256-61. PubMed ID: 21917554
[TBL] [Abstract][Full Text] [Related]
31. Effects of hormone replacement therapy on perceptual and cognitive event-related potentials in menopausal insomnia.
Anderer P; Semlitsch HV; Saletu B; Saletu-Zyhlarz G; Gruber D; Metka M; Huber J; Gräser T; Oettel M
Psychoneuroendocrinology; 2003 Apr; 28(3):419-45. PubMed ID: 12573306
[TBL] [Abstract][Full Text] [Related]
32. Heavy uterine bleeding in women with endometriosis and adenomyosis treated with dienogest.
Chou FW; Chang WH; Wang PH
Taiwan J Obstet Gynecol; 2024 Mar; 63(2):139-140. PubMed ID: 38485301
[No Abstract] [Full Text] [Related]
33. Progesterone and synthetic progestin, dienogest, induce apoptosis of human primary cultures of adenomyotic stromal cells.
Yamanaka A; Kimura F; Kishi Y; Takahashi K; Suginami H; Shimizu Y; Murakami T
Eur J Obstet Gynecol Reprod Biol; 2014 Aug; 179():170-4. PubMed ID: 24953822
[TBL] [Abstract][Full Text] [Related]
34. Subtype I (intrinsic) adenomyosis is an independent risk factor for dienogest-related serious unpredictable bleeding in patients with symptomatic adenomyosis.
Matsubara S; Kawaguchi R; Akinishi M; Nagayasu M; Iwai K; Niiro E; Yamada Y; Tanase Y; Kobayashi H
Sci Rep; 2019 Nov; 9(1):17654. PubMed ID: 31776404
[TBL] [Abstract][Full Text] [Related]
35. Long-term treatment of endometriosis with dienogest: retrospective analysis of efficacy and safety in clinical practice.
Römer T
Arch Gynecol Obstet; 2018 Oct; 298(4):747-753. PubMed ID: 30076546
[TBL] [Abstract][Full Text] [Related]
36. Effect of long-term continuous combined hormone replacement therapy with estradiol valerate and either dienogest or norethisterone acetate on mammographic density in postmenopausal women.
Georgiev DB; Manassiev NA
Medscape Womens Health; 2002; 7(4):1. PubMed ID: 12466733
[TBL] [Abstract][Full Text] [Related]
37. Clinical profiles of 710 premenopausal women with adenomyosis who underwent hysterectomy.
Li X; Liu X; Guo SW
J Obstet Gynaecol Res; 2014 Feb; 40(2):485-94. PubMed ID: 24148010
[TBL] [Abstract][Full Text] [Related]
38. Effect of a contraceptive pill containing estradiol valerate and dienogest (E2V/DNG) in women with menstrually-related migraine (MRM).
Nappi RE; Terreno E; Sances G; Martini E; Tonani S; Santamaria V; Tassorelli C; Spinillo A
Contraception; 2013 Sep; 88(3):369-75. PubMed ID: 23453784
[TBL] [Abstract][Full Text] [Related]
39. Maintenance therapy with dienogest following gonadotropin-releasing hormone agonist treatment for endometriosis-associated pelvic pain.
Kitawaki J; Kusuki I; Yamanaka K; Suganuma I
Eur J Obstet Gynecol Reprod Biol; 2011 Aug; 157(2):212-6. PubMed ID: 21474232
[TBL] [Abstract][Full Text] [Related]
40. Continuous-combined treatment of the menopause with combinations of oestradiol valerate and dienogest - a dose-ranging study.
Gräser T; Müller A; Mellinger U; Mück AO; Lippert TH; Oettel M
Maturitas; 2000 Jun; 35(3):253-61. PubMed ID: 10936742
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
